FDA Approved: PIRFENIDONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz Inc's supplemental application for pirfenidone, a generic version of Esbriet, for the treatment of idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (generic) (pirfenidone)

Snippet

SUPPL AP for PIRFENIDONE (PIRFENIDONE)